Structures by: Bertolasi V.
Total: 325
C14H17ClN3O4S2Tc
C14H17ClN3O4S2Tc
Journal of the Chemical Society, Dalton Transactions (1998) 9 1453
a=8.238(1)Å b=14.169(1)Å c=8.427(1)Å
α=90.00(0)° β=105.54(1)° γ=90.00(0)°
C54H56Cu4N8O8,Na,ClO4
C54H56Cu4N8O8,Na,ClO4
Dalton transactions (Cambridge, England : 2003) (2013) 42, 34 12495-12506
a=35.6139(6)Å b=35.6139(6)Å c=11.47320(10)Å
α=90.0000° β=90.0000° γ=120.0000°
C51H76Cu2N4O4,1.5(H2O)
C51H76Cu2N4O4,1.5(H2O)
Dalton transactions (Cambridge, England : 2003) (2013) 42, 34 12495-12506
a=23.2607(12)Å b=19.7554(10)Å c=28.1663(14)Å
α=90.00° β=101.9139(15)° γ=90.00°
C22H29N6Ni2O6,NO3,0.5(H2O)
C22H29N6Ni2O6,NO3,0.5(H2O)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 5 1970-1973
a=18.5183(16)Å b=18.5183(16)Å c=17.4171(15)Å
α=90.00° β=90.00° γ=90.00°
C13H11AgClN3
C13H11AgClN3
RSC Adv. (2014) 4, 105 60776
a=7.460(3)Å b=9.046(4)Å c=9.952(4)Å
α=83.312(5)° β=72.451(8)° γ=87.187(8)°
C12H8N4O16Y,C24H20As
C12H8N4O16Y,C24H20As
Dalton transactions (Cambridge, England : 2003) (2014) 43, 26 10120-10131
a=10.7426(2)Å b=13.4270(2)Å c=14.1483(3)Å
α=71.1379(6)° β=78.6566(6)° γ=85.7839(6)°
C50H46Cu4N8O11
C50H46Cu4N8O11
Dalton transactions (Cambridge, England : 2003) (2015) 44, 13 6107-6117
a=14.9238(7)Å b=14.9238(7)Å c=23.7779(11)Å
α=90.00° β=90.00° γ=90.00°
C54H56Cu4N6O11
C54H56Cu4N6O11
Dalton transactions (Cambridge, England : 2003) (2015) 44, 13 6107-6117
a=14.7994(6)Å b=14.7994(6)Å c=23.9708(14)Å
α=90.00° β=90.00° γ=90.00°
C34H30Br2NO8PPd,CH2Cl2
C34H30Br2NO8PPd,CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 33 15049-15058
a=11.7017(1)Å b=26.5544(3)Å c=12.1475(1)Å
α=90.00° β=100.5665(4)° γ=90.00°
C33H28Br2NO8PPd
C33H28Br2NO8PPd
Dalton transactions (Cambridge, England : 2003) (2015) 44, 33 15049-15058
a=13.9247(2)Å b=13.3155(2)Å c=18.1663(2)Å
α=90.00° β=96.4251(8)° γ=90.00°
C34H30I2NO8PPd,CH2Cl2
C34H30I2NO8PPd,CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 33 15049-15058
a=11.8881(1)Å b=27.2222(3)Å c=12.0742(2)Å
α=90.00° β=100.7290(5)° γ=90.00°
C25H27BrClNO8PdS
C25H27BrClNO8PdS
Dalton transactions (Cambridge, England : 2003) (2016) 45, 28 11560-11567
a=9.8374(2)Å b=17.9906(7)Å c=17.3653(5)Å
α=90.00° β=91.8460(18)° γ=90.00°
C38H46ClN2Rh
C38H46ClN2Rh
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 561-571
a=23.2672(6)Å b=14.4735(2)Å c=22.2443(7)Å
α=90.00° β=114.7300(10)° γ=90.00°
C38H46ClN2Rh
C38H46ClN2Rh
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 561-571
a=15.1213(5)Å b=11.1057(3)Å c=20.3596(7)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>,<i>N</i>'-(1,4-Phenylene)bis(<i>O</i>,<i>O</i>'-dimethylthiophosphoramidate)
C10H18N2O4P2S2
Acta Crystallographica Section C (2018) 74, 12
a=13.2517(3)Å b=10.0091(2)Å c=13.9580(3)Å
α=90° β=112.9309(12)° γ=90°
<i>N</i>,<i>N</i>'-(Cyclohexane-1,4-diyl)bis(<i>O</i>,<i>O</i>'-diphenylphosphoramide)
C30H32N2O6P2
Acta Crystallographica Section C (2018) 74, 12
a=10.2789(5)Å b=10.8253(4)Å c=15.0200(6)Å
α=101.229(4)° β=105.716(4)° γ=109.782(4)°
C24H38O5
C24H38O5
Acta Crystallographica Section B (2005) 61, 3 346-356
a=6.31220(10)Å b=10.8884(2)Å c=32.0624(7)Å
α=90.00° β=90.00° γ=90.00°
C24H38O5
C24H38O5
Acta Crystallographica Section B (2005) 61, 3 346-356
a=8.98790(10)Å b=9.40280(10)Å c=26.4369(4)Å
α=90.00° β=90.00° γ=90.00°
C24H36O5
C24H36O5
Acta Crystallographica Section B (2005) 61, 3 346-356
a=10.2677(4)Å b=7.1108(2)Å c=15.2270(6)Å
α=90.00° β=92.3400(10)° γ=90.00°
C24H36O5
C24H36O5
Acta Crystallographica Section B (2005) 61, 3 346-356
a=8.49530(10)Å b=12.7060(2)Å c=20.8011(3)Å
α=90.00° β=90.00° γ=90.00°
C24H34O5
C24H34O5
Acta Crystallographica Section B (2005) 61, 3 346-356
a=12.0863(3)Å b=6.8301(2)Å c=13.1153(4)Å
α=90.00° β=101.1380(10)° γ=90.00°
N-benzo[1,3]-dioxol-5-yl-2-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,9- tetrahydro-1H-purin-8-yl)-1-methyl-1-H-pyrazol-3-iloxy] -acetamide formylhydrazine hydrate
C24H27N7O6,CH4N2O,H2O
Acta Crystallographica Section B (2005) 61, 5 569-576
a=7.6900(2)Å b=9.6995(2)Å c=20.1404(5)Å
α=80.5220(10)° β=86.7920(10)° γ=72.3300(16)°
C24H36O5,1/2(H2O)
C24H36O5,1/2(H2O)
Acta Crystallographica Section B (2005) 61, 3 346-356
a=26.6049(4)Å b=7.70440(10)Å c=22.9126(3)Å
α=90.00° β=93.4240(10)° γ=90.00°
C10H9N3O2
C10H9N3O2
Acta Crystallographica Section B (1994) 50, 5 617-625
a=11.100(3)Å b=7.960(2)Å c=21.744(4)Å
α=90° β=95.82(2)° γ=90°
C10H8N4O4
C10H8N4O4
Acta Crystallographica Section B (1994) 50, 5 617-625
a=7.046(2)Å b=7.7740(10)Å c=20.917(4)Å
α=90° β=98.09(2)° γ=90°
C10H8ClN3O2
C10H8ClN3O2
Acta Crystallographica Section B (1994) 50, 5 617-625
a=18.324(2)Å b=5.7710(10)Å c=20.016(2)Å
α=90° β=90° γ=90°
C16H13N5O3
C16H13N5O3
Acta Crystallographica Section B (1994) 50, 5 617-625
a=12.8170(10)Å b=7.595(5)Å c=15.652(3)Å
α=90° β=95.740(10)° γ=90°
4,5-dihydronaphto[1,2-d]-1H,3-methylpyrazole hemihydrochloride
C12H12N2,C12H13N2,Cl
Acta Crystallographica Section B (1999) 55, 6 985-993
a=8.1900(10)Å b=14.463(2)Å c=18.115(3)Å
α=90.00° β=96.200(10)° γ=90.00°
E,2-(4-cyanophenylhydrazono)-3-oxobutanenitrile
C11H8N4O
Acta Crystallographica Section B (1999) 55, 6 994-1004
a=7.196(3)Å b=14.125(2)Å c=10.862(2)Å
α=90.00° β=97.34(3)° γ=90.00°
3-hydroxy-5-methyl-4-(3'-methylpyrazol-5'-yl)pyrazole
C8H10N4O
Acta Crystallographica Section B (1999) 55, 6 985-993
a=16.409(3)Å b=7.6190(10)Å c=13.544(6)Å
α=90.00° β=90.00° γ=90.00°
E,2-(4-methylphenylhydrazono)-3-oxobutanenitrile
C11H11N3O
Acta Crystallographica Section B (1999) 55, 6 994-1004
a=7.052(2)Å b=13.211(2)Å c=11.996(2)Å
α=90.00° β=104.96(2)° γ=90.00°
E,2-(4-acetylphenylhydrazono)-3-oxobutanenitrile
C12H11N3O2
Acta Crystallographica Section B (1999) 55, 6 994-1004
a=8.638(3)Å b=10.841(2)Å c=12.208(2)Å
α=90.00° β=94.69(2)° γ=90.00°
E,2-(2-methylphenylhydrazono)-3-oxobutanenitrile
C11H11N3O2
Acta Crystallographica Section B (1999) 55, 6 994-1004
a=15.236(2)Å b=6.6180(10)Å c=11.3790(10)Å
α=90.00° β=90.00° γ=90.00°
E,2-(2-acetylphenylhydrazono)-3-oxobutanenitrile
C12H11N3O2
Acta Crystallographica Section B (1999) 55, 6 994-1004
a=6.878(2)Å b=8.2410(10)Å c=11.3950(10)Å
α=105.210(10)° β=96.62(2)° γ=102.92(2)°
E, 2-(2-nitrophenylhydrazono)-3-oxobutanenitrile
C10H8N4O3
Acta Crystallographica Section B (1999) 55, 6 994-1004
a=7.1840(10)Å b=19.491(2)Å c=8.0840(10)Å
α=90.00° β=109.270(10)° γ=90.00°
3-(4-Methoxyphenylamino)-5-methyl-2-cyclohexen-1-one
C14H17NO2
Acta Crystallographica Section B (1998) 54, 1 50-65
a=5.6040(10)Å b=13.667(2)Å c=16.742(3)Å
α=90.00000° β=95.020(10)° γ=90.00000°
3-Phenylamino-5,5-dimethyl-2-cyclohexen-1-one
C14H17NO
Acta Crystallographica Section B (1998) 54, 1 50-65
a=9.4930(10)Å b=13.061(3)Å c=10.3050(10)Å
α=90.00000° β=105.510(10)° γ=90.00000°
C15H19NO2
C15H19NO2
Acta Crystallographica Section B (1998) 54, 1 50-65
a=27.458(4)Å b=7.180(2)Å c=14.210(2)Å
α=90.00000° β=90.00000° γ=90.00000°
N,N'-3-azapentane-1,5-bis[1-(3-oxo-5,5-dimethyl-1-cyclohexenyl)]
C20H33N3O2
Acta Crystallographica Section B (1998) 54, 1 50-65
a=31.779(5)Å b=5.7140(10)Å c=11.334(5)Å
α=90.00000° β=92.76(3)° γ=90.00000°
3-Phenylamino-6,6-dimethyl-2-cyclohexen-1-one
C14H17NO
Acta Crystallographica Section B (1998) 54, 1 50-65
a=9.6080(10)Å b=11.248(2)Å c=12.096(4)Å
α=106.38(2)° β=91.22(2)° γ=98.910(10)°
3-(2-methoxyphenylamino)-6,6-dimethyl-2-cyclohexen-1-one
C15H19NO2
Acta Crystallographica Section B (1998) 54, 1 50-65
a=10.5460(10)Å b=14.205(4)Å c=18.323(2)Å
α=90.00000° β=90.00000° γ=90.00000°
3-(3-Chlorophenylamino)-6,6-dimethyl-2-cyclohexen-1-one
C14H16ClNO
Acta Crystallographica Section B (1998) 54, 1 50-65
a=7.3130(10)Å b=11.7780(10)Å c=8.0170(10)Å
α=90.00000° β=107.260(10)° γ=90.00000°
3-(4-Chlorophenylamino)-6,6-dimethyl-2-cyclohexen-1-one
C14H16ClNO
Acta Crystallographica Section B (1998) 54, 1 50-65
a=9.756(3)Å b=11.983(2)Å c=12.0430(10)Å
α=101.530(10)° β=91.99(2)° γ=98.83(2)°
1-(4-Chlorophenyl)-4-(4-chlorophenylamino)-6-methyl-2-pyridone
C18H14Cl2N2O
Acta Crystallographica Section B (1998) 54, 1 50-65
a=14.244(2)Å b=9.6450(10)Å c=23.711(3)Å
α=90.00000° β=90.00000° γ=90.00000°
3-(4-Chlorophenylamino)-5-phenyl-2-cyclopenten-1,4-dione
C17H12ClNO2
Acta Crystallographica Section B (1998) 54, 1 50-65
a=7.075(2)Å b=13.332(2)Å c=15.030(2)Å
α=90.00000° β=95.17(2)° γ=90.00000°
8-aminoquinolinium . squarate, 1:2
2(C9H9N2),C4O4
Acta Crystallographica Section B (2001) 57, 4 591-598
a=7.2090(10)Å b=7.8610(10)Å c=8.4430(10)Å
α=108.070(10)° β=91.620(10)° γ=89.830(10)°
3-aminopyridinium . hydrogen squarate, 1:1
C5H7N2,C4HO4
Acta Crystallographica Section B (2001) 57, 4 591-598
a=3.8120(10)Å b=11.012(2)Å c=21.942(5)Å
α=100.78(2)° β=91.66(2)° γ=88.26(2)°
4-aminopyridinium . hydrogen squarate, 1:1
C5H7N2,C4HO4
Acta Crystallographica Section B (2001) 57, 4 591-598
a=10.283(3)Å b=7.0680(10)Å c=12.642(2)Å
α=90.00° β=97.95(2)° γ=90.00°
Tris(2-hydroxy-6-methyl-pyridine) phloroglucinol hydrate
C6H6O3,3(C6H7NO),H2O
Acta Crystallographica Section B (2016) 72, 3 326-334
a=12.2625(5)Å b=14.1634(7)Å c=15.4250(9)Å
α=90° β=113.8431(16)° γ=90°
Phloroglucinol bis(2-hydroxy-pyridine)
C6H6O3,2(C5H5NO)
Acta Crystallographica Section B (2016) 72, 3 326-334
a=7.7275(3)Å b=19.8281(10)Å c=11.3080(6)Å
α=90.00° β=117.679(2)° γ=90.00°
Phloroglucinol tris(2,4-dimethyl-6-hydroxy-pyrimidine)
C6H6O3,3(C6H8N2O)
Acta Crystallographica Section B (2016) 72, 3 326-334
a=7.7212(2)Å b=12.4488(2)Å c=14.2673(3)Å
α=112.6081(11)° β=95.5610(9)° γ=93.5410(9)°
Bis(4-phenyl-pyridine) phloroglucinol
C6H6O3,2(C11H9N)
Acta Crystallographica Section B (2016) 72, 3 326-334
a=18.4503(4)Å b=7.3939(2)Å c=18.7699(5)Å
α=90.00° β=114.9241(13)° γ=90.00°
Bis(phloroglucinol) tris(2,3,5,6- tetramethylpyrazine)
3(C8H12N2),2(C6H6O3)
Acta Crystallographica Section B (2016) 72, 3 326-334
a=15.6225(4)Å b=13.5010(3)Å c=17.2314(5)Å
α=90.00° β=90.2350(10)° γ=90.00°
C14H13HClNO6
C14H13HClNO6
Acta Crystallographica, Section B (2006) 62, 4 850-863
a=5.68490(10)Å b=9.0280(2)Å c=14.8742(4)Å
α=74.9230(10)° β=83.543(2)° γ=71.815(2)°
(2Z)-1-(2-hydroxyphenyl)-3-phenyl-1,3-propanedione enol
C15H12O3
Acta Crystallographica, Section B (2006) 62, 4 850-863
a=27.299(2)Å b=5.4343(2)Å c=17.5760(10)Å
α=90.00° β=116.215(2)° γ=90.00°
(2Z)-1-(2-hydroxy-5-chlorophenyl)-3-phenyl-1,3-propanedione enol
C15H11ClO3
Acta Crystallographica, Section B (2006) 62, 4 850-863
a=13.9320(10)Å b=5.3108(2)Å c=17.8780(10)Å
α=90.00° β=105.137(3)° γ=90.00°
(2Z)-1-(2-hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione enol
C16H14O3
Acta Crystallographica, Section B (2006) 62, 4 850-863
a=17.6020(10)Å b=6.8423(2)Å c=21.6620(10)Å
α=90.00° β=90.00° γ=90.00°
(2Z)-1-(2-hydroxy-4-methyl-5-chlorophenyl)-3-phenyl-1,3-propanedione enol
C16H13ClO3
Acta Crystallographica, Section B (2006) 62, 4 850-863
a=14.1470(10)Å b=5.3300(3)Å c=18.618(2)Å
α=90.00° β=104.777(4)° γ=90.00°
C22H19NO
C22H19NO
Acta Crystallographica Section B (2006) 62, 6 1112-1120
a=8.9727(2)Å b=9.7552(2)Å c=10.0208(2)Å
α=89.0810(10)° β=71.0020(10)° γ=85.7860(10)°
C15H17NO3
C15H17NO3
Acta Crystallographica Section B (2006) 62, 6 1112-1120
a=14.0608(3)Å b=6.64070(10)Å c=14.4581(3)Å
α=90.00° β=107.3120(10)° γ=90.00°
C22H19NO2
C22H19NO2
Acta Crystallographica Section B (2006) 62, 6 1112-1120
a=14.2380(3)Å b=14.3109(3)Å c=16.8047(3)Å
α=90.00° β=90.00° γ=90.00°
C15H17NO3
C15H17NO3
Acta Crystallographica Section B (2006) 62, 6 1112-1120
a=7.7200(2)Å b=8.9566(3)Å c=9.5777(3)Å
α=93.830(2)° β=92.083(2)° γ=105.755(2)°
8-Methyl-8-azabiciclo[3.2.1]oct-3-yl-3,5-dichlorobenzoate (MDL 72222)
C15H17Cl2NO2
Acta Crystallographica Section B (1996) 52, 3 509-518
a=8.480(3)Å b=9.840(3)Å c=10.158(4)Å
α=90.04(3)° β=111.77(3)° γ=105.07(3)°
1-(2-Methoxyphenyl)-4-[-(2-phtalimido)butylpiperazine hydrobromide emihydrate (NAN-190.HBr)
C23H28N3O3,Br1,0.5H2O
Acta Crystallographica Section B (1996) 52, 3 509-518
a=21.916(4)Å b=15.207(2)Å c=14.052(2)Å
α=90.00000° β=101.560(10)° γ=90.00000°
N-Phenyl-imidocarbonimidic diamide (1-Phenylbiguanide)
C8H11N5
Acta Crystallographica Section B (1996) 52, 3 509-518
a=9.781(2)Å b=35.040(5)Å c=11.000(2)Å
α=90.00000° β=97.720(10)° γ=90.00000°
1,2,3,4,10,14b-Hexahydro-2-methyldibenzo[c,f]pyrizino [1,2-a]azepine hydrochloride (Mianserin.HCl)
C18H21N2,Cl1
Acta Crystallographica Section B (1996) 52, 3 509-518
a=9.014(2)Å b=14.917(2)Å c=12.412(2)Å
α=90.00000° β=108.840(10)° γ=90.00000°
C10H11NO
C10H11NO
Acta Crystallographica Section B (1995) 51, 6 1004-1015
a=9.132(3)Å b=12.931(3)Å c=15.514(5)Å
α=90.0° β=90.0° γ=90.0°
C11H13NO
C11H13NO
Acta Crystallographica Section B (1995) 51, 6 1004-1015
a=10.004(3)Å b=10.482(3)Å c=11.506(4)Å
α=114.54(2)° β=111.28(2)° γ=88.16(3)°
C11H13NO3
C11H13NO3
Acta Crystallographica Section B (1995) 51, 6 1004-1015
a=9.469(2)Å b=8.530(3)Å c=27.149(3)Å
α=90.0° β=90.0° γ=90.0°
C14H11NO2
C14H11NO2
Acta Crystallographica Section B (1995) 51, 6 1004-1015
a=8.4690(10)Å b=15.783(2)Å c=9.0030(10)Å
α=90.0° β=90.0° γ=90.0°
C20H18N4O
C20H18N4O
Acta Crystallographica Section B (1995) 51, 6 1004-1015
a=11.793(4)Å b=7.9200(10)Å c=18.366(2)Å
α=90.0° β=100.01(2)° γ=90.0°
C16H10ClNO2
C16H10ClNO2
Acta Crystallographica Section B (1995) 51, 6 1004-1015
a=4.8230(10)Å b=22.371(3)Å c=11.814(3)Å
α=90.0° β=97.04(2)° γ=90.0°
C13H13N5O
C13H13N5O
Acta Crystallographica Section B (1995) 51, 6 1004-1015
a=18.970(3)Å b=5.770(2)Å c=23.578(4)Å
α=90.0° β=97.22(2)° γ=90.0°
3-Phenylamino-2-cyclohexen-1-one
C12H13NO
Acta Crystallographica Section B (1998) 54, 1 50-65
a=6.112(3)Å b=11.1730(10)Å c=14.428(2)Å
α=90.00000° β=90.79(3)° γ=90.00000°
3-(4-Methoxyphenylamino)-2-cyclohexen-1-one
C13H15NO2
Acta Crystallographica Section B (1998) 54, 1 50-65
a=5.226(2)Å b=14.047(2)Å c=16.134(2)Å
α=90.00000° β=96.48(2)° γ=90.00000°
3-(4-Chlorophenylamino)-2-cyclohexen-1-one
C12H12ClNO
Acta Crystallographica Section B (1998) 54, 1 50-65
a=5.9080(10)Å b=13.5830(10)Å c=14.058(2)Å
α=90.00000° β=96.18(2)° γ=90.00000°
3-(4-Methoxyphenylamino)-2-methyl-2-cyclohexen-1-one
C14H17NO2
Acta Crystallographica Section B (1998) 54, 1 50-65
a=7.0790(10)Å b=15.996(3)Å c=11.231(3)Å
α=90.00000° β=92.78(2)° γ=90.00000°
3-Hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridin-1-ium 4-hydroxy-3,5-dimethoxybenzoate monohydrate
C9H9O5,C8H12NO3[solvent]
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1064-1070
a=6.9085(2)Å b=8.4524(2)Å c=17.9702(5)Å
α=101.8010(16)° β=92.7110(16)° γ=109.8290(14)°
3-Hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridin-1-ium (<i>E</i>)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate monohydrate
C8H12NO3,C10H11O5,H2O
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1064-1070
a=7.2440(3)Å b=17.1615(5)Å c=7.2706(2)Å
α=90° β=98.806(2)° γ=90°
6-(2-Thienyl)-9-(2-phenylethyl)-9H-purine
C16H12N4S
Acta Crystallographica Section E (2001) 57, 11 o1052-o1054
a=10.1130(4)Å b=8.9101(2)Å c=15.6434(7)Å
α=90.00° β=96.8550(17)° γ=90.00°
C10H12F2N2O4
C10H12F2N2O4
Acta Crystallographica Section C (1996) 52, 10 2615-2616
a=4.837(1)Å b=13.296(1)Å c=18.240(1)Å
α=90.° β=90.° γ=90.°
C15H11ClO2
C15H11ClO2
Acta Crystallographica Section C (1992) 48, 10 1798-1801
a=24.324(4)Å b=6.537(2)Å c=15.598(2)Å
α=90° β=93.520(10)° γ=90°
C17H11AuBrN5
C17H11AuBrN5
Acta Crystallographica Section C (1992) 48, 5 814-817
a=13.229(2)Å b=11.069(2)Å c=12.8490(10)Å
α=90° β=117.92(9)° γ=90°
C8H6N4O5
C8H6N4O5
Acta Crystallographica Section C (1993) 49, 4 741-744
a=7.8450(10)Å b=6.462(3)Å c=18.920(4)Å
α=90° β=93.18(2)° γ=90°
C19H22ClN5O4
C19H22ClN5O4
Acta Crystallographica Section C (1995) 51, 11 2408-2409
a=11.346(2)Å b=12.305(1)Å c=14.327(1)Å
α=90° β=90° γ=90°
5-Phenyluridine trihydrate
C15H16N2O6,3H2O
Acta Crystallographica Section E (2007) 63, 9 o3805-o3805
a=7.36270(10)Å b=14.0874(3)Å c=16.7287(3)Å
α=90° β=90° γ=90°
C20H18F3NO6S
C20H18F3NO6S
The Journal of organic chemistry (2015) 80, 18 9176-9184
a=9.4706(2)Å b=7.52610(10)Å c=14.8394(4)Å
α=90.00° β=101.1490(8)° γ=90.00°
C16H10N2O2
C16H10N2O2
Journal of Organic Chemistry (2004) 69, 6927-6930
a=8.1918(3)Å b=11.1780(5)Å c=13.5924(7)Å
α=90.00° β=96.4920(19)° γ=90.00°
C10H8N2O2
C10H8N2O2
Journal of Organic Chemistry (2004) 69, 6927-6930
a=14.4551(3)Å b=16.5721(5)Å c=8.0504(4)Å
α=90.00° β=90.00° γ=90.00°
C15H12N2O
C15H12N2O
Journal of Organic Chemistry (2006) 71, 819-822
a=15.8732(3)Å b=13.5038(3)Å c=16.9982(3)Å
α=90.00° β=99.468(2)° γ=90.00°
C19H31N3O6
C19H31N3O6
Journal of Organic Chemistry (2003) 68, 6172-6183
a=5.8209(2)Å b=15.1688(4)Å c=24.5767(9)Å
α=90.00° β=90.00° γ=90.00°
C61H52N2O2P3Re
C61H52N2O2P3Re
Organometallics (2006) 25, 2 416-426
a=19.9767(2)Å b=19.9099(2)Å c=25.8490(2)Å
α=90.00° β=90.00° γ=90.00°
C61H52N2O2P3ReS,0.5(CH2Cl2)
C61H52N2O2P3ReS,0.5(CH2Cl2)
Organometallics (2006) 25, 2 416-426
a=13.7255(2)Å b=14.2675(2)Å c=17.4984(3)Å
α=71.0420(6)° β=76.4760(7)° γ=61.3240(6)°
C63H54N2O2P3Re,2(CH2Cl2)
C63H54N2O2P3Re,2(CH2Cl2)
Organometallics (2006) 25, 2 416-426
a=13.6973(2)Å b=14.3060(2)Å c=17.9666(3)Å
α=70.7666(6)° β=78.3629(5)° γ=63.8146(8)°
C64H54N3O2P3Re,C24H20B,C1H2Cl2
C64H54N3O2P3Re,C24H20B,C1H2Cl2
Organometallics (2006) 25, 2 416-426
a=10.7561(1)Å b=18.3415(2)Å c=20.4445(2)Å
α=68.8734(4)° β=83.3823(4)° γ=81.3935(6)°
C61H53N2O2P3ReS,BC24H20,C3H8O,CH4O
C61H53N2O2P3ReS,BC24H20,C3H8O,CH4O
Organometallics (2006) 25, 2 416-426
a=12.9736(2)Å b=18.6676(3)Å c=18.9829(3)Å
α=117.5604(7)° β=107.3454(8)° γ=93.8150(9)°
C14H26N4O3PPd,ClO4
C14H26N4O3PPd,ClO4
Organometallics (2009) 28, 11 3247
a=11.6637(2)Å b=9.5738(2)Å c=19.8507(4)Å
α=90.00° β=96.5022(7)° γ=90.00°
C30H33AuN3,BF4,CH2Cl2
C30H33AuN3,BF4,CH2Cl2
Organometallics (2011) 30, 4 875
a=12.4567(2)Å b=15.8378(3)Å c=17.4139(4)Å
α=90.00° β=91.5986(7)° γ=90.00°
C35H44AuN4,BF4
C35H44AuN4,BF4
Organometallics (2011) 30, 4 875
a=13.7923(4)Å b=21.4354(8)Å c=24.0185(10)Å
α=90.00° β=90.00° γ=90.00°
C44H61Cl2N2PRu
C44H61Cl2N2PRu
Organometallics (2009) 28, 17 4988
a=45.8607(5)Å b=9.91970(10)Å c=19.7087(3)Å
α=90.00° β=111.0768(5)° γ=90.00°